This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2021 May;93(5):1034-1037.

doi: 10.1016/j.gie.2021.01.041.

From bench to bedside: Is it time to incorporate molecular testing for diagnostic and management algorithms for pancreatic cystic lesions?

Jennifer M Bailey-Lundberg¹, Sushovan Guha², Nirav Thosani²

Affiliations

Affiliations

¹ Center for Interventional Gastroenterology at the University of Texas, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA; Department of Anesthesiology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
² Center for Interventional Gastroenterology at the University of Texas, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA; Division of Gastroenterology and Hepatology, Department of Internal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA.

PMID: 33875142
DOI: 10.1016/j.gie.2021.01.041

Editorial

From bench to bedside: Is it time to incorporate molecular testing for diagnostic and management algorithms for pancreatic cystic lesions?

Jennifer M Bailey-Lundberg et al. Gastrointest Endosc. 2021 May.

. 2021 May;93(5):1034-1037.

doi: 10.1016/j.gie.2021.01.041.

Authors

Jennifer M Bailey-Lundberg¹, Sushovan Guha², Nirav Thosani²

Affiliations

¹ Center for Interventional Gastroenterology at the University of Texas, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA; Department of Anesthesiology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
² Center for Interventional Gastroenterology at the University of Texas, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA; Division of Gastroenterology and Hepatology, Department of Internal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA.

PMID: 33875142
DOI: 10.1016/j.gie.2021.01.041

No abstract available

PubMed Disclaimer

Comment on

Molecular analysis of EUS-acquired pancreatic cyst fluid for KRAS and GNAS mutations for diagnosis of intraductal papillary mucinous neoplasia and mucinous cystic lesions: a systematic review and meta-analysis.
McCarty TR, Paleti S, Rustagi T. McCarty TR, et al. Gastrointest Endosc. 2021 May;93(5):1019-1033.e5. doi: 10.1016/j.gie.2020.12.014. Epub 2021 Mar 26. Gastrointest Endosc. 2021. PMID: 33359054

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal